ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Immunomodulatory Approaches to Treating Chronic Rhinosinusitis Gain Importance

by Thomas R. Collins • November 1, 2013

  • Tweet
  • Email
Print-Friendly Version

 

You Might Also Like

  • Saline Irrigation Effective in Treating CRS
  • Change in Cardinal Symptoms of Chronic Rhinosinusitis Observed
  • Tips for Treating Chronic Rhinosinusitis with Nasal Irrigation
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?
Explore This Issue
November 2013

Color-enhanced X-ray depicting left maxillary sinusitis.

VANCOUVER—Immunomodulatory approaches are of growing importance in the treatment of chronic rhinosinusitis (CRS), said a panel of experts gathered here at the 2013 AAO-HNS Annual Meeting. Panelists covered a range of key points in this area, including the prevalence of immunodeficiency in CRS, the role of topical steroids, challenges involved in battling eosinophils and emerging immunomodulatory therapies in CRS.

Rakesh Chandra, MD, associate professor of otolaryngology-head and neck surgery at Northwestern University in Chicago, said anatomical adjustments don’t get at the root cause of CRS. “These anatomic causes are really not the primary etiology for most chronic rhinosinusitis,” he said. “And, when we do surgery, what we’re doing is compensating for all of these other causes by making the anatomy bigger.”

There is a strong link between immunodeficiency and CRS, he said. A French study of 252 patients with infections and common variable immunodeficiency (CVID) found that 36 percent of them had sinusitis (Clin Infect Dis. 2008;46:1547-1554). At Northwestern, 595 patients with CRS were screened, and 33 percent had some kind of immunodeficiency: 24 percent with specific antibody deficiency, 6 percent with common variable immunodeficiency, and 3 percent with IgA deficiency.

Treatment options for antibody deficiency include immune globulin replacement in CVID and the vaccine Prevnar. A drop in infections has also been found with the use of immune globulin treatment in patients with specific antibody deficiency, Dr. Chandra said.

As for surgery, a study of 22 ambulatory patients with immune dysfunction found that sinus surgery improved endoscopy scores and quality of life in those patients at a level similar to that achieved with controls (Am J Rhinol Allergy. 2010;24:230-233). “We can help these patients, but to really know about what’s wrong with them, we need to have a lower threshold to screen them,” Dr. Chandra said.

Topical Steroids

Topical steroids play an important role in treating CRS patients, but choosing the ideal strategy can be difficult, said Pete Batra, MD, associate professor of otolaryngology-head and neck surgery at the University of Texas Southwestern in Dallas. “Our goal in surgery is to create cavities that will allow optimal installation of topical therapies,” he added. “The issue is, what do you use?”

The options range from standard topical nasal steroids, to off-label steroid drops, to nebulizers, and physician-directed treatments like drug-eluting stents, gels and injections. Standard nasal steroids have shown efficacy in symptom reduction and polyp scores (Cochrane Database Syst Rev. 2012;12:CD006549).

Pages: 1 2 3 4 | Single Page

Filed Under: Features, Practice Focus, Rhinology Tagged With: AAO-HNS annual meeting, chronic rhinosinusitis, immunodeficiency, Immunomodulatory, therapiesIssue: November 2013

You Might Also Like:

  • Saline Irrigation Effective in Treating CRS
  • Change in Cardinal Symptoms of Chronic Rhinosinusitis Observed
  • Tips for Treating Chronic Rhinosinusitis with Nasal Irrigation
  • Is Topical Amphotericin B Efficacious in the Treatment of Chronic Rhinosinusitis?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.